Patent Ownership and the Impact of Interactions with Others

Dr. Breier’s practice focuses on patent prosecution, client counseling, and PTAB proceedings in the biotechnology and pharmaceutical areas. He coordinates global prosecution strategies, prepares domestic and foreign patent applications, performs freedom-to-operate, patentability, invalidity, and noninfringement analyses, and participates in post-grant administrative trials such as inter partes reviews. Dr. Breir has a special interest in subject matter including biochemical and biophysical analytical compositions, methods, and apparatuses; polymer chemistry; engineered or recombinant DNA, RNA, and proteins; and genetically modified cells. He also has prosecution experience with new chemical entities and with compositions and formulations in which hydrophobic or amphipathic materials such as lipids, polymers, or surfactants provide new and useful features. Dr. Breir has worked with domestic and foreign clients, including research institutions, startups, and established biotechnology, pharmaceutical, and chemical companies.

Ms. McNeill offers intellectual property strategy and advises on new application preparation, patent prosecution (U.S. and foreign), and preparation and negotiation of IP transactions, and provides the full scope of counseling services. She has a special interest in counseling clients on patent application filing and developing worldwide prosecution strategies in concert with clients’ business goals. She has managed and directed the U.S. and international patent portfolios for U.S. clients and has overseen the U.S. patent portfolio for international clients in Europe and Asia.